Sequans Communications, a Paris-based IoT semiconductor firm, sold 344 Bitcoin in Q2 2026 and plans to divest its remaining 314 BTC, exiting its crypto treasury strategy that once held over 3,200 BTC. The company is refocusing on its core IoT chip business after using Bitcoin sale proceeds to fully repay convertible debt. Despite a 23% revenue increase and $5.3 million net gain from Bitcoin sales in Q2, Sequans still posted a $9.8 million net loss. The company aims to take a disciplined approach to selling the remaining Bitcoin and become a debt-free pure-play IoT chipmaker.
Rocket Lab has secured a $397 million contract from the U.S. Space Force to develop, launch, and operate advanced Flatellites under the Space-Based Airborne Moving Target Indicator (SB-AMTI) program. This initiative aims to enhance real-time airborne...
Bunge Global SA saw a director purchase 1,500 shares at $107.60, signaling insider confidence. Analysts have set a mean price target of $138.30, implying a 28.3% upside, driven by strong Q2 performance in soybeans and softseeds that raised earnings o...
Qualys reported strong Q2 2026 results, with earnings per share of $1.98 surpassing the $1.78 consensus and revenue of $182.2 million, an 11% year-over-year increase. The company raised its full-year 2026 revenue guidance to $732-$738 million, reflec...
Stocks fell sharply due to various factors including a 58.71% drop in the Defiance Daily Target 2x Short PLTR ETF, driven by strong gains in Palantir Technologies, which the ETF inversely tracks. AdaptHealth shares dropped 38.09% amid a legal investi...
Pomerantz LLP is investigating Karyopharm Therapeutics for potential securities fraud related to a retention program granting top executives lump sum cash bonuses between $625,000 and $1,725,000. The announcement led to a 21.45% drop in Karyopharm's ...
